Patterns of occurrence and implications of neratinib-associated diarrhea in patients with HER2-positive breast cancer: analyses from the randomized phase III ExteNET trial

BACKGROUND: We characterized patterns of occurrence and the impact of neratinib-associated diarrhea in the absence of protocol-directed antidiarrheal prophylaxis or a formal diarrhea management plan using data from Extended Adjuvant Treatment of Breast Cancer with Neratinib (ExteNET). METHODS: ExteN...

Descripción completa

Detalles Bibliográficos
Autores principales: Mortimer, Joanne, Di Palma, Jack, Schmid, Kendra, Ye, Yining, Jahanzeb, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391844/
https://www.ncbi.nlm.nih.gov/pubmed/30813966
http://dx.doi.org/10.1186/s13058-019-1112-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391844/
https://www.ncbi.nlm.nih.gov/pubmed/30813966
http://dx.doi.org/10.1186/s13058-019-1112-5

Ejemplares similares